|
1
|
Jiang G, Wang D, Li W, Pan Y, Zheng W,
Zhang H and Sun YV: Coronary heart disease mortality in China: Age,
gender, and urban-rural gaps during epidemiological transition. Rev
Panam Salud Publica. 31:317–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bäck M and Hansson GK: Anti-inflammatory
therapies for atherosclerosis. Nat Rev Cardiol. 12:199–211. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Libby P: Inflammation in atherosclerosis.
Arterioscler Thromb Vasc Biol. 32:2045–2051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Vascular smooth muscle cell in atherosclerosis. Acta Physiol
(Oxf). 214:33–50. 2015. View Article : Google Scholar
|
|
5
|
Meng Z, Yan C, Deng Q, Gao DF and Niu XL:
Curcumin inhibits LPS-induced inflammation in rat vascular smooth
muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways.
Acta Pharmacol Sin. 34:901–911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pacurari M, Kafoury R, Tchounwou PB and
Ndebele K: The renin-angiotensin-aldosterone system in vascular
inflammation and remodeling. Int J Inflam. 2014:6893602014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Askari AT, Shishehbor MH, Kaminski MA,
Riley MJ, Hsu A and Lincoff AM; GUSTO-V Investigators: The
association between early ventricular arrhythmias,
renin-angiotensin-aldosterone system antagonism, and mortality in
patients with ST-segment-elevation myocardial infarction: insights
from Global Use of Strategies to Open Coronary Arteries (GUSTO) V.
Am Heart J. 158:238–243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Derosa G and Maffioli P: Peroxisome
proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic
control, lipid profile and cardiovascular risk. Curr Mol Pharmacol.
5:272–281. 2012. View Article : Google Scholar
|
|
9
|
Usuda D and Kanda T: Peroxisome
proliferator-activated receptors for hypertension. World J Cardiol.
6:744–754. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fuentes E, Guzmán-Jofre L, Moore-Carrasco
R and Palomo I: Role of PPARs in inflammatory processes associated
with metabolic syndrome (Review). Mol Med Rep. 8:1611–1616.
2013.PubMed/NCBI
|
|
11
|
Liu WX, Wang T, Zhou F, Wang Y, Xing JW,
Zhang S, Gu SZ, Sang LX, Dai C and Wang HL: Voluntary exercise
prevents colonic inflammation in high-fat diet-induced obese mice
by up-regulating PPAR-gamma activity. Biochem Biophys Res Commun.
459:475–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marchesi C, Rehman A, Rautureau Y, Kasal
DA, Briet M, Leibowitz A, Simeone SM, Ebrahimian T, Neves MF,
Offermanns S, et al: Protective role of vascular smooth muscle cell
PPARγ in angiotensin II-induced vascular disease. Cardiovasc Res.
97:562–570. 2013. View Article : Google Scholar
|
|
13
|
Ji Y, Liu J, Wang Z, Liu N and Gou W:
PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced
vascular inflammation through the TLR4-dependent signaling pathway.
Lab Invest. 89:887–902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng Z, Yu XH, Chen J, Li L and Li S:
Curcumin attenuates cardiac fibrosis in spontaneously hypertensive
rats through PPAR-γ activation. Acta Pharmacol Sin. 35:1247–1256.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Horke S and Förstermann U: Vascular
oxidative stress, nitric oxide and atherosclerosis.
Atherosclerosis. 237:208–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Madamanchi NR and Runge MS: NADPH oxidases
and atherosclerosis: Unraveling the details. Am J Physiol Heart
Circ Physiol. 298:H1–H2. 2010. View Article : Google Scholar
|
|
17
|
Barry-Lane PA, Patterson C, van der Merwe
M, Hu Z, Holland SM, Yeh ET and Runge MS: p47phox is required for
atherosclerotic lesion progression in ApoE(−/−) mice. J Clin
Invest. 108:1513–1522. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kinkade K, Streeter J and Miller FJ:
Inhibition of NADPH oxidase by apocynin attenuates progression of
atherosclerosis. Int J Mol Sci. 14:17017–17028. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008. View Article : Google Scholar
|
|
20
|
Barzegar A and Moosavi-Movahedi AA:
Intracellular ROS protection efficiency and free radical-scavenging
activity of curcumin. PLoS One. 6:e260122011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Feng HL, Fan H, Dang HZ, Chen XP, Ren Y,
Yang JD and Wang PW: Neuroprotective effect of curcumin to Aβ of
double transgenic mice with Alzheimer's disease. Zhongguo Zhong Yao
Za Zhi. 39:3846–3849. 2014.In Chinese.
|
|
22
|
Sahebkar A: Dual effect of curcumin in
preventing atherosclerosis: The potential role of
pro-oxidant-antioxidant mechanisms. Nat Prod Res. 29:491–492. 2015.
View Article : Google Scholar
|
|
23
|
Griendling KK, Taubman MB, Akers M,
Mendlowitz M and Alexander RW: Characterization of
phosphatidylinositol-specific phospholipase C from cultured
vascular smooth muscle cells. J Biol Chem. 266:15498–15504.
1991.PubMed/NCBI
|
|
24
|
Van Hoogmoed LM, Snyder JR and Harmon F:
In vitro investigation of the effect of prostaglandins and
nonsteroidal anti-inflammatory drugs on contractile activity of the
equine smooth muscle of the dorsal colon, ventral colon, and pelvic
flexure. Am J Vet Res. 61:1259–1266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong JM, Choi CH, Kang SK, Lee IH, Lee JY
and Jung H: Antioxidant and chemosensitizing effects of flavonoids
with hydroxy and/or methoxy groups and structure-activity
relationship. J Pharm Pharm Sci. 10:537–546. 2007. View Article : Google Scholar
|
|
26
|
Mehta JL and Romeo F: Inflammation,
infection and atherosclerosis: Do antibacterials have a role in the
therapy of coronary artery disease? Drugs. 59:159–170. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peters S: Inhibition of atherosclerosis by
angiotensin II type 1 receptor antagonists. Am J Cardiovasc Drugs.
13:221–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Durante A, Peretto G, Laricchia A, Ancona
F, Spartera M, Mangieri A and Cianflone D: Role of the
renin-angiotensin-aldosterone system in the pathogenesis of
atherosclerosis. Curr Pharm Des. 18:981–1004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu Z, Wang M, Gucek M, Zhang J, Wu J,
Jiang L, Monticone RE, Khazan B, Telljohann R and Mattison J: Milk
fat globule protein epidermal growth factor-8: A pivotal relay
element within the angiotensin II and monocyte chemoattractant
protein-1 signaling cascade mediating vascular smooth muscle cells
invasion. Circ Res. 104:1337–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kawashima S: The two faces of endothelial
nitric oxide synthase in the pathophysiology of atherosclerosis.
Endothelium. 11:99–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bunderson M, Coffin JD and Beall HD:
Arsenic induces peroxynitrite generation and cyclooxygenase-2
protein expression in aortic endothelial cells: Possible role in
atherosclerosis. Toxicol Appl Pharmacol. 184:11–18. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Detmers PA, Hernandez M, Mudgett J,
Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock
J, et al: Deficiency in inducible nitric oxide synthase results in
reduced atherosclerosis in apolipoprotein E-deficient mice. J
Immunol. 165:3430–3435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grygiel-Górniak B: Peroxisome
proliferator-activated receptors and their ligands: Nutritional and
clinical implications - a review. Nutr J. 13:172014. View Article : Google Scholar
|
|
34
|
Azhar S: Peroxisome proliferator-activated
receptors, metabolic syndrome and cardiovascular disease. Future
Cardiol. 6:657–691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsumura T, Kinoshita H, Ishii N, Fukuda
K, Motoshima H, Senokuchi T, Taketa K, Kawasaki S, Nishimaki-Mogami
T, Kawada T, et al: Telmisartan exerts antiatherosclerotic effects
by activating peroxisome proliferator-activated receptor-γ in
macrophages. Arterioscler Thromb Vasc Biol. 31:1268–1275. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Siddiqui AM, Cui X, Wu R, Dong W, Zhou M,
Hu M, Simms HH and Wang P: The anti-inflammatory effect of curcumin
in an experimental model of sepsis is mediated by up-regulation of
peroxisome proliferator-activated receptor-gamma. Crit Care Med.
34:1874–1882. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ghosh SS, Massey HD, Krieg R, Fazelbhoy
ZA, Ghosh S, Sica DA, Fakhry I and Gehr TW: Curcumin ameliorates
renal failure in 5/6 nephrectomized rats: Role of inflammation. Am
J Physiol Renal Physiol. 296:F1146–F1157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fu Y, Zheng S, Lin J, Ryerse J and Chen A:
Curcumin protects the rat liver from CCl4-caused injury
and fibrogenesis by attenuating oxidative stress and suppressing
inflammation. Mol Pharmacol. 73:399–409. 2008. View Article : Google Scholar
|
|
39
|
Tousoulis D, Psaltopoulou T, Androulakis
E, Papageorgiou N, Papaioannou S, Oikonomou E, Synetos A and
Stefanadis C: Oxidative stress and early atherosclerosis: Novel
antioxidant treatment. Cardiovasc Drugs Ther. 29:75–88. 2015.
View Article : Google Scholar
|
|
40
|
Li H, Horke S and Förstermann U: Oxidative
stress in vascular disease and its pharmacological prevention.
Trends Pharmacol Sci. 34:313–319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun GB, Qin M, Ye JX, Pan RL, Meng XB,
Wang M, Luo Y, Li ZY, Wang HW and Sun XB: Inhibitory effects of
myricitrin on oxidative stress-induced endothelial damage and early
atherosclerosis in ApoE−/− mice. Toxicol Appl Pharmacol.
271:114–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hort MA, Straliotto MR, Netto PM, da Rocha
JB, de Bem AF and Ribeiro-do-Valle RM: Diphenyl diselenide
effectively reduces atherosclerotic lesions in LDLr−/−
mice by attenuation of oxidative stress and inflammation. J
Cardiovasc Pharmacol. 58:91–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rong S, Zhao Y, Bao W, Xiao X, Wang D,
Nussler AK, Yan H, Yao P and Liu L: Curcumin prevents chronic
alcohol-induced liver disease involving decreasing ROS generation
and enhancing antioxidative capacity. Phytomedicine. 19:545–550.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D,
Guo S, Ming Z and Liu C: Curcumin alleviates diabetic
cardiomyopathy in experimental diabetic rats. PLoS One.
7:e520132012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bruder-Nascimento T, Chinnasamy P,
Riascos-Bernal DF, Cau SB, Callera GE, Touyz RM, Tostes RC and
Sibinga NE: Angiotensin II induces Fat1 expression/activation and
vascular smooth muscle cell migration via Nox1-dependent reactive
oxygen species generation. J Mol Cell Cardiol. 66:18–26. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gray SP, Di Marco E, Okabe J,
Szyndralewiez C, Heitz F, Montezano AC, de Haan JB, Koulis C,
El-Osta A, Andrews KL, et al: NADPH oxidase 1 plays a key role in
diabetes mellitus-accelerated atherosclerosis. Circulation.
127:1888–1902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ushio-Fukai M: Localizing NADPH
oxidase-derived ROS. Sci STKE. 2006:re82006.PubMed/NCBI
|
|
48
|
Zhao WC, Zhang B, Liao MJ, Zhang WX, He
WY, Wang HB and Yang CX: Curcumin ameliorated diabetic neuropathy
partially by inhibition of NADPH oxidase mediating oxidative stress
in the spinal cord. Neurosci Lett. 560:81–85. 2014. View Article : Google Scholar
|
|
49
|
Derochette S, Franck T, Mouithys-Mickalad
A, Ceusters J, Deby-Dupont G, Lejeune JP, Neven P and Serteyn D:
Curcumin and resveratrol act by different ways on NADPH oxidase
activity and reactive oxygen species produced by equine
neutrophils. Chem Biol Interact. 206:186–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
